Agent Capital
Agent Capital is a healthcare venture capital firm that invests in novel, differentiated therapeutics and treatments addressing unmet patient needs. The firm invests across all stages of development and works with scientists, entrepreneurs and co-investors to advance biotech programs toward clinical and commercial milestones and exits.
Agent Capital
Services
Equity and growth capital
Provides venture financing across stages and investment types to biotechnology companies.
Strategic guidance to milestones and exits
Proactively guides portfolio companies to technical and business milestones and toward exits.
Syndicate and partnership alignment
Aligns with other investors, strategic collaborators and scientific founders to structure financings and collaborations.
Equity and growth capital
Provides venture financing across stages and investment types to biotechnology companies.
Strategic guidance to milestones and exits
Proactively guides portfolio companies to technical and business milestones and toward exits.
Syndicate and partnership alignment
Aligns with other investors, strategic collaborators and scientific founders to structure financings and collaborations.
Portfolio
#Therapeutics
#Diagnostics / Oncology
#Genome engineering / Synthetic biology
Series B financing of $62M to support clinical trials in IPF and PSC; Agent Capital participated in the round.
#Fibrosis therapeutics
#Biotherapeutics
#Immuno-oncology / Biologics
#Therapeutics
#Diagnostics / Oncology
#Genome engineering / Synthetic biology
Series B financing of $62M to support clinical trials in IPF and PSC; Agent Capital participated in the round.
#Fibrosis therapeutics
#Biotherapeutics
#Immuno-oncology / Biologics